| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| A Marbini, F Gemignani, M F Bellanova, D Guidetti, A Ferrar. Immunohistochemical localization of utrophin and other cytoskeletal proteins in skin smooth muscle in neuromuscular diseases. Journal of the neurological sciences. vol 143. issue 1-2. 1997-03-20. PMID:8981315. |
staining of the capillary endothelial cells and muscular vessel walls was seen in normal controls, as well as in dmd, bmd, and other neuromuscular diseases. |
1997-03-20 |
2023-08-12 |
Not clear |
| I Nonak. [Muscle pathologic diagnosis--mechanism in muscle fiber degeneration]. Rinsho shinkeigaku = Clinical neurology. vol 34. issue 12. 1995-07-11. PMID:7774135. |
in various neuromuscular diseases, the most significant muscle degeneration is muscle fiber necrosis as seen in duchenne muscular dystrophy (dmd). |
1995-07-11 |
2023-08-12 |
mouse |
| A Oldfors, T Martinsson, I Tessin, J Wahlström, S Wan. Duchenne muscular dystrophy and spinal muscular atrophy type I segregating in the same family. Clinical genetics. vol 45. issue 2. 1994-07-19. PMID:8004806. |
we report on a family with two severe neuromuscular diseases: duchenne muscular dystrophy (dmd) and acute infantile spinal muscular atrophy (sma i). |
1994-07-19 |
2023-08-12 |
Not clear |
| R Mongiorgi, A C Ballestrazzi, C Granata, G Bertocchi, G Maggi, S Gnudi, M G Gandolf. Morphological and structural characteristics of the myopathic bone. Bollettino della Societa italiana di biologia sperimentale. vol 69. issue 5. 1994-04-15. PMID:8129910. |
to this end, samples from 8 patients affected by different neuromuscular diseases (dmd, sma and cmd) have been examined. |
1994-04-15 |
2023-08-12 |
Not clear |
| J E Anderson, D L Lentz, R B Johnso. Recovery from disuse osteopenia coincident to restoration of muscle strength in mdx mice. Bone. vol 14. issue 4. 1994-02-08. PMID:8274305. |
these observations suggest that data are needed regarding bone mass and muscle-bone attachments in humans with disuse osteopenia, dmd, and other neuromuscular diseases. |
1994-02-08 |
2023-08-12 |
mouse |
| Y K Hayashi, E Engvall, E Arikawa-Hirasawa, K Goto, R Koga, I Nonaka, H Sugita, K Arahat. Abnormal localization of laminin subunits in muscular dystrophies. Journal of the neurological sciences. vol 119. issue 1. 1994-01-05. PMID:8246011. |
to address potential involvement of muscle basal lamina and membrane cytoskeleton proteins in the etiology of non-dystrophinopathy muscular dystrophies, we examined the immunostaining intensity and distribution of laminin subunits (a, b1, b2 and m), type iv collagen, dystrophin and spectrin in skeletal muscle biopsies from 64 myopathic patients (17 fukuyama congenital muscular dystrophy: fcmd, 13 congenital muscular dystrophy unrelated to fcmd: other cmd, 16 duchenne muscular dystrophy: dmd, and 18 other neuromuscular diseases. |
1994-01-05 |
2023-08-12 |
Not clear |
| A S Oliveira, A A Gabbai, B Schmidt, B H Kiyomoto, J G Lima, C Minetti, E Bonill. Carrier detection of Duchenne and Becker muscular dystrophy using muscle dystrophin immunohistochemistry. Arquivos de neuro-psiquiatria. vol 50. issue 4. 1993-10-21. PMID:1309152. |
this method is also helpful to distinguish manifesting dmd carriers from patients with other neuromuscular diseases like limb-girdle muscular dystrophy and spinal muscular atrophy. |
1993-10-21 |
2023-08-11 |
Not clear |
| D G Cziner, R I Levi. The cardiomyopathy of Duchenne's muscular dystrophy and the function of dystrophin. Medical hypotheses. vol 40. issue 3. 1993-07-01. PMID:8502196. |
duchenne's muscular dystrophy (dmd) is a common x-linked neuromuscular disease which predominantly affects skeletal and cardiac muscle. |
1993-07-01 |
2023-08-12 |
Not clear |
| K Ohlendieck, K Matsumura, V V Ionasescu, J A Towbin, E P Bosch, S L Weinstein, S W Sernett, K P Campbel. Duchenne muscular dystrophy: deficiency of dystrophin-associated proteins in the sarcolemma. Neurology. vol 43. issue 4. 1993-05-11. PMID:8469343. |
the results revealed a dramatic reduction in all of the dystrophin-associated proteins in the sarcolemma of dmd muscle compared with normal muscle and muscle from a variety of other neuromuscular diseases. |
1993-05-11 |
2023-08-12 |
Not clear |
| O Yahara, K Hashimoto, N Taniguchi, M Ishikawa, Y Sato, H Yamashita, H Ohn. Serum manganese-superoxide dismutase in patients with neuromuscular disorders as judged by an ELISA. Research communications in chemical pathology and pharmacology. vol 72. issue 3. 1991-12-13. PMID:1947435. |
manganese-superoxide dismutase (mn-sod) concentration was measured in sera from 37 healthy controls and 101 patients with 11 forms of neuromuscular diseases including duchenne muscular dystrophy (dmd) and polymyositis (pms) by an enzyme-linked immunosorbent assay with the use of a monoclonal antibody against human liver mn-sod. |
1991-12-13 |
2023-08-11 |
human |
| K Matsumura, T Toda, T Hasegawa, M Kamei, N Imoto, T Shimiz. A Japanese family with two types of muscular dystrophy: DNA analysis and the dystrophin test. Journal of child neurology. vol 6. issue 3. 1991-09-26. PMID:1875028. |
four boys, all from the sixth generation of the same family, were afflicted with severe neuromuscular diseases beginning in early life, three of them presenting the typical phenotype of fcmd and one, that of dmd. |
1991-09-26 |
2023-08-11 |
Not clear |
| T M Ko, C F Chen, H C Chiu, F J Hsieh, T Y Le. Molecular analysis of 25 Chinese families with Duchenne/Becker muscular dystrophy. Journal of the Formosan Medical Association = Taiwan yi zhi. vol 89. issue 10. 1991-04-23. PMID:1981771. |
duchenne muscular dystrophy (dmd) and becker muscular dystrophy (bmd) are allelic x-linked progressive neuromuscular diseases. |
1991-04-23 |
2023-08-11 |
human |
| C Webster, H M Bla. Accelerated age-related decline in replicative life-span of Duchenne muscular dystrophy myoblasts: implications for cell and gene therapy. Somatic cell and molecular genetics. vol 16. issue 6. 1991-02-12. PMID:2267630. |
we compared the life-span of myoblasts from eight dmd patients with controls: three individuals with no known neuromuscular disease, three dmd carriers, and three patients with other muscle degenerative diseases. |
1991-02-12 |
2023-08-11 |
Not clear |
| K M Jaffe, C M McDonald, E Ingman, J Haa. Symptoms of upper gastrointestinal dysfunction in Duchenne muscular dystrophy: case-control study. Archives of physical medicine and rehabilitation. vol 71. issue 10. 1990-10-19. PMID:2403280. |
subjects included 55 children with confirmed dmd and 55 age-matched controls without neuromuscular disease. |
1990-10-19 |
2023-08-11 |
human |
| M Uchino, S Araki, T Miike, H Teramoto, T Nakamura, T Yasutak. Localization and characterization of dystrophin in muscle biopsy specimens from Duchenne muscular dystrophy and various neuromuscular disorders. Muscle & nerve. vol 12. issue 12. 1990-03-20. PMID:2695839. |
in normal controls and in patients with various neuromuscular diseases other than dmd and becker's muscular dystrophy (bmd), dystrophin was detected homogeneously on the entire surface membrane of the muscle fibers, whereas it was absent in dmd patients and partially observed in bmd cases. |
1990-03-20 |
2023-08-11 |
mouse |
| L M Kunkel, A H Beggs, E P Hoffma. Molecular genetics of Duchenne and Becker muscular dystrophy: emphasis on improved diagnosis. Clinical chemistry. vol 35. issue 7 Suppl. 1989-08-22. PMID:2663232. |
the severely affected dmd patients have little or no detectable dystrophin in their muscle, whereas bmd patients have nearly normal concentrations of an altered form of dystrophin; patients with all other neuromuscular diseases have normal dystrophin. |
1989-08-22 |
2023-08-11 |
human |
| H Stedman, S Sarka. Molecular genetics in muscular dystrophy research: revolutionary progress. Muscle & nerve. vol 11. issue 7. 1988-09-22. PMID:3043215. |
the contribution of "reverse genetic" strategies to neuromuscular disease research is evident in the progression of breakthroughs that have recently culminated in the cloning of the duchenne muscular dystrophy (dmd) cdna. |
1988-09-22 |
2023-08-11 |
Not clear |
| S R Braun, R L Sufit, R Giovannoni, M O'Connor, H Peter. Intermittent negative pressure ventilation in the treatment of respiratory failure in progressive neuromuscular disease. Neurology. vol 37. issue 12. 1987-12-28. PMID:3683880. |
five men with degenerative neuromuscular diseases (three with amyotrophic lateral sclerosis [als] and two with duchenne's muscular dystrophy [dmd]) who had respiratory failure were treated with intermittent negative pressure ventilation (npv). |
1987-12-28 |
2023-08-11 |
Not clear |
| E Bakker, C Van Broeckhoven, E J Bonten, M J van de Vooren, H Veenema, W Van Hul, G J Van Ommen, A Vandenberghe, P L Pearso. Germline mosaicism and Duchenne muscular dystrophy mutations. Nature. vol 329. issue 6139. 1987-11-09. PMID:2889144. |
duchenne muscular dystrophy (dmd) is a severe x-linked neuromuscular disease with an incidence of approximately 1 in 3,500 newborn boys. |
1987-11-09 |
2023-08-11 |
Not clear |
| G R Freidenberg, J M Olefsk. Dissociation of insulin resistance and decreased insulin receptor binding in Duchenne muscular dystrophy. The Journal of clinical endocrinology and metabolism. vol 60. issue 2. 1985-02-21. PMID:3965491. |
duchenne muscular dystrophy (dmd) is an x-linked inherited neuromuscular disease characterized by progressive weakness and severe muscle wasting. |
1985-02-21 |
2023-08-11 |
human |